Skip to main content

Pharmabrand Labs Pty Ltd

Regulatory activities for this sponsor.

Sponsor content

1 result(s) found, displaying 1 to 1
  • Regulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s26A(2)(c) and (j) were incorrect. The goods also did not conform to a requirement relating to advertising applicable to the goods under Part 5-1 of the Act., effective 05/07/2013

Help us improve the Therapeutic Goods Administration site